Brent L Saunders insider trades
Open-market stock purchases and sales by Brent L Saunders, Chairman of the Board and CEO at Bausch & Lomb Corp, from SEC Form 4 filings since Aug 23, 2011.
Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +37%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 5, 2026 | BLCO Bausch & Lomb Corp | Sold (not open market) | $70.9K |
| Aug 5, 2026 | BLCO Bausch & Lomb Corp | Bought (not open market) | — |
| Jun 24, 2026 | SPRY ARS Pharmaceuticals, Inc | Bought (not open market) | — |
| May 22, 2026 | BLCO Bausch & Lomb Corp | Sold (not open market) | $45.9K |
| Mar 6, 2026 | BLCO Bausch & Lomb Corp | Bought | $252K |
| Mar 6, 2026 | BLCO Bausch & Lomb Corp | Bought (not open market) | — |
| Feb 27, 2026 | BLCO Bausch & Lomb Corp | Sold (not open market) | $451K |
| Feb 26, 2026 | BLCO Bausch & Lomb Corp | Sold (not open market) | $408K |
| Feb 25, 2026 | BLCO Bausch & Lomb Corp | Bought (not open market) | — |
| Feb 23, 2026 | BLCO Bausch & Lomb Corp | Sold (not open market) | $1.2M |
Companies traded
- BLCO Bausch & Lomb Corp: 3 buys, last Aug 5, 2026
- SPRY ARS Pharmaceuticals, Inc: 1 sale, last Jun 24, 2026
- SKIN Beauty Health Co: 2 buys, last Jun 16, 2025
- CSCO Cisco Systems, Inc: other filings, last Dec 8, 2022
- BBIO BridgeBio Pharma, Inc: 1 buy, last Jun 22, 2022
- AGN Allergan plc: 10 buys, last May 8, 2020
- ACT Actavis plc: other filings, last May 15, 2015
- FRX Forest Laboratories, LLC: other filings, last Jul 1, 2014